Dividend criteria checks 0/6
Insulet Corporation does not have a record of paying a dividend.
|Industry average yield||1.7%|
|Next dividend pay date||n/a|
|Ex dividend date||n/a|
|Dividend per share||US$0|
|Earnings per share||US$0.24|
|Dividend yield forecast in 3Y||0%|
Recent dividend updates
Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt BurdenJan 24
Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To ContinueDec 28
Insulet: An Overpriced Play In The Medical SpaceOct 18
Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance SheetOct 02
Insulet automated insulin delivery system Omnipod 5 gets CE markSep 20
The Return Trends At Insulet (NASDAQ:PODD) Look PromisingSep 05
Insulet wins FDA nod to use insulin delivery system in 2 – 5-year-oldsAug 22
Insulet: Bullish Factors For Portfolio InclusionJul 23
Insulet to pay $20M to Roche in patent settlementJul 11
Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)Jun 06
Is Insulet (NASDAQ:PODD) Using Too Much Debt?May 16
Insulet Q1 2022 Earnings Preview: A Great Growth Story At A Very High PriceMay 04
Insulet: Heroic Assumptions Still RequiredFeb 23
Insulet (NASDAQ:PODD) Has A Somewhat Strained Balance SheetJan 25
Insulet (NASDAQ:PODD) Is Looking To Continue Growing Its Returns On CapitalNov 08
Insulet: Heroic Assumptions RequiredOct 29
Insulet (NASDAQ:PODD) Has A Somewhat Strained Balance SheetOct 12
Insulet: Omnipod's Creator At Ominous Levels Ahead Of Horizon LaunchAug 01
Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)Aug 01
If You Like EPS Growth Then Check Out Insulet (NASDAQ:PODD) Before It's Too LateJun 24
Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt BurdenMay 06
If You Had Bought Insulet (NASDAQ:PODD) Stock Five Years Ago, You Could Pocket A 740% Gain TodayMar 02
Does Insulet's (NASDAQ:PODD) Statutory Profit Adequately Reflect Its Underlying Profit?Feb 09
Is Insulet (NASDAQ:PODD) Using Too Much Debt?Jan 22
Insulet (PODD) Presents At 39th Annual Healthcare Conference - SlideshowJan 14
Is Insulet Corporation's (NASDAQ:PODD) ROE Of 4.9% Concerning?Jan 07
Dividend Yield vs Market
|Insulet Dividend Yield vs Market|
|Market Bottom 25% (US)||1.5%|
|Market Top 25% (US)||4.2%|
|Industry Average (Medical Equipment)||1.7%|
|Analyst forecast in 3 Years (PODD)||0%|
Notable Dividend: Unable to evaluate PODD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PODD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
|Month||Dividend Per Share (annual)||Avg. Yield (%)|
Stable Dividend: Insufficient data to determine if PODD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PODD's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PODD has not reported any payouts.